Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Metagenomic insights of the infant microbiome community structure and function across multiple sites in the United States. Scientific reports Casaburi, G. n., Duar, R. M., Brown, H. n., Mitchell, R. D., Kazi, S. n., Chew, S. n., Cagney, O. n., Flannery, R. L., Sylvester, K. G., Frese, S. A., Henrick, B. M., Freeman, S. L. 2021; 11 (1): 1472

Abstract

The gut microbiome plays an important role in early life, protecting newborns from enteric pathogens, promoting immune system development and providing key functions to the infant host. Currently, there are limited data to broadly assess the status of the US healthy infant gut microbiome. To address this gap, we performed a multi-state metagenomic survey and found high levels of bacteria associated with enteric inflammation (e.g. Escherichia, Klebsiella), antibiotic resistance genes, and signatures of dysbiosis, independent of location, age, and diet. Bifidobacterium were less abundant than generally expected and the species identified, including B. breve, B. longum and B. bifidum, had limited genetic capacity to metabolize human milk oligosaccharides (HMOs), while B. infantis strains with a complete capacity for HMOs utilization were found to be exceptionally rare. Considering microbiome composition and functional capacity, this survey revealed a previously unappreciated dysbiosis that is widespread in the contemporary US infant gut microbiome.

View details for DOI 10.1038/s41598-020-80583-9

View details for PubMedID 33479326